Navigation Links
DelMar Pharmaceuticals to Present Interim Clinical Data for VAL-083 in Glioblastoma at Society of Neuro-Oncology
Date:11/14/2013

VANCOUVER, British Columbia and MENLO PARK, Calif., Nov. 14, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced that the Company will present interim clinical trial data for VAL-083 in glioblastoma at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO) being held in conjunction with the 18th Annual Society for Neuro-Oncology (SNO) meeting. The WFNO/SNO meeting will take place November 21st through 24th in San Francisco.  Glioblastoma is the most common and aggressive form of brain cancer, and new therapies are greatly needed.

DelMar will present the poster entitled, "Phase I/II study of VAL-083 in patients with recurrent malignant glioma or progressive-secondary brain tumor," from 7 pm to 9 pm on Friday, November 22nd. The abstract, number MR-028, is now published in the Journal of Neuro-Oncology and can also be found by clicking here.

About VAL-083
VAL-083 represents a first-in-class, small-molecule chemotherapeutic with a unique mechanism of action. In more than 40 Phase 1 and 2 clinical studies sponsored by the National Cancer Institute (NCI), VAL-083 has shown safety and efficacy in treating a number of cancers including lung, brain, cervical, ovarian tumors and leukemia. VAL-083 is approved in China for the treatment of chronic myelogenous leukemia and lung cancer and has received orphan drug designation in Europe and the U.S. for the treatment of gliomas.  As a potential treatment for glioblastoma, VAL-083's mechanism of action is unaffected by the expression of MGMT
'/>"/>

SOURCE DelMar Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
2. DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement
3. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
4. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
5. DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant
6. DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock Conference
7. DelMar Pharma Named to Rocket Builders 2013"Ready to Rocket" List
8. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
9. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
10. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
11. DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... YORK and HERZLIYA PITUACH, Israel ... "Company") (NASDAQ: IMNP ) announced today that its ... the Board succeeding Dr. Daniel Teper who continues ... a member of Immune,s Board of Directors since 2013. ... "I am delighted to represent the interest of shareholders and ...
(Date:12/15/2014)... , Dec. 15, 2014  Colorado and ... have legalized adult use of cannabis. Oregon ... D.C. ended prohibition during the November 2014 elections. ... Photo - http://photos.prnewswire.com/prnh/20141212/164153LOGO The benefits ... noted and obvious benefits like the increased tax revenue for ...
(Date:12/15/2014)... , Dec. 15, 2014  Stephen Squires, CEO and ... Quantum Materials Corp (OTCQB:QTMM), will be speaking at ... Materials (RCQM) on December 16th, 2014. The RCQM launch ... nanomaterials in attracting top faculty and students and by ... on research. "We have a long ...
Breaking Medicine Technology:Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 3Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 4CannaInsider.com Estimates 200,000 New Jobs in the Cannabis Industry by 2015 2Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 2Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 3
... AVIV, Israel, October 12 Elbit Imaging Ltd.,(NASDAQ: ... ,2009 it sold a,total of 4,794,292 ordinary shares of ... to a number of Polish,institutional investors. The aggregate consideration ... (approximately $10.6 million),representing a price of 6.5 Polish Zlotys ...
... China, Oct. 11 Merial, the Animal Health ... SNY ), announced today that Merial Animal Health Co. (China) ... plant located in the Nanchang Hi-tech Development Zone, China. ... and the Group,s first production facility in China has been ...
Cached Medicine Technology:Elbit Imaging Ltd. Announces Sale of Plaza Centers Shares 2Elbit Imaging Ltd. Announces Sale of Plaza Centers Shares 3Merial invests US $70 million in Nanchang, China 2Merial invests US $70 million in Nanchang, China 3
(Date:12/17/2014)... Unidesk Corporation today announced that ... welcomed its inaugural class in August 2013, has ... support bring your own device (BYOD) and deliver ... The solution, comprised of Citrix XenDesktop ... and storage infrastructure and Unidesk virtual ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 No matter ... been able to eradicate the head louse parasite—a common ... for parents. Each year between six and twelve million ... the Miami-based lice removal treatment company comes to the ... and environmentally friendly. With its track record of customer ...
(Date:12/17/2014)... (HealthDay News) -- Expectant parents should leave prenatal picture-taking ... recommends. Use of ultrasound imaging and heartbeat monitors ... risk-free, the agency warns. "Although there is ... ultrasound imaging and heartbeat monitors, prudent use of these ... Vaezy, an FDA biomedical engineer, said in an agency ...
(Date:12/17/2014)... Kathleen Doheny HealthDay ... Chronic sleep loss is rampant in America, and work commitment ... is the No. 1 sleep killer," said Dr. Mathias Basner, ... the University of Pennsylvania Perelman School of Medicine. A ... older, found that work is the main activity exchanged for ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
Breaking Medicine News(10 mins):Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 2Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 3Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3
... HealthDay Reporter , TUESDAY, June 28 (HealthDay News) -- ... U.S. regulators, attention again Tuesday during a two-day hearing to ... the treatment of metastatic breast cancer. Back on Dec. ... of the drug to fight breast cancer, citing the ...
... University School of Medicine in St. Louis are performing ... irregular heartbeat. Available at only a handful of ... surgical techniques with the latest advances in catheter ablation, ... surface to block signals causing the heart to misfire. ...
... care nurses doubt that a clinical neurological examination can establish ... perceive that this uncertainty can affect relatives when the question ... from the Sahlgrenska Academy, University of Gothenburg, Sweden. ... caring for patients who are brain dead and who by ...
... with social interaction and attentiveness, and are also sensitive ... evident to parents during their child,s first two years, ... of Gothenburg. In her thesis, Dewrang investigated ... relative to their diagnosis. The thesis is based on ...
... mutations for two classes of p7 inhibitor, which may ... with current standard of care. Study results support the ... future HCV-specific therapies and are available in the July ... Wiley-Blackwell on behalf of the American Association for the ...
... regulated, as mistakes may lead to cancer. The so-called c-JUN ... and liver. The group of Veronika Sexl at the ... detail with the discovery an additional function of c-JUN,s also ... have recently been published in the open-access journal Oncotarget ...
Cached Medicine News:Health News:FDA to Hear Appeal on Breast Cancer Drug 2Health News:FDA to Hear Appeal on Breast Cancer Drug 3Health News:New procedure treats atrial fibrillation 2Health News:New procedure treats atrial fibrillation 3Health News:New procedure treats atrial fibrillation 4Health News:Intensive care nurses have doubts about method for establishing brain death 2Health News:Intensive care nurses have doubts about method for establishing brain death 3Health News:P7 protein resistance mutations identified; represent drug targets for hepatitis C virus 2Health News:The good, the bad and the ugly: The many roles of c-JUN in cancer 2
... operation for stent delivery. Uses perpendicular ... movement. Allows user to adjust stent ... Maintains tactile feel via fine adjustment ... in visualization at any angle. The ...
Vial with 100 Urine Reagent Test Strips, tests for glucose, protein, pH, blood, ketone, bilirubin, nitrite, urobilinogen, specific gravity. FOR LABORATORY USE BY QUALIFIED TECHNICIANS....
... the latest from Quality Mapping Solutions, ... designed specifically for implementing and managing ... superior design, functionality, security, and versatility ... managing a quality program., ,Based upon ...
... Q-Pulse is the UK's market-leading system ... 250 pathology laboratories in the UK ... In addition, hundreds of pathology laboratories ... South Africa and the United States ...
Medicine Products: